Ganfeng Lithium Co., Limited (1772.HK)
HKD 19.04
(4.27%)
HKD 19.04
(4.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 25.23 Billion CNY | 97.23% |
| 2022 | 12.79 Billion CNY | 100.52% |
| 2021 | 6.38 Billion CNY | 4.3% |
| 2020 | 6.11 Billion CNY | 45.87% |
| 2019 | 4.19 Billion CNY | 51.07% |
| 2018 | 2.77 Billion CNY | 26.29% |
| 2017 | 2.19 Billion CNY | 269.64% |
| 2016 | 594.63 Million CNY | 102.44% |
| 2015 | 293.73 Million CNY | -12.18% |
| 2014 | 334.47 Million CNY | 22.1% |
| 2013 | 273.94 Million CNY | 287.37% |
| 2012 | 70.71 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 60.96 Million CNY | -23.61% |
| 2008 | 79.8 Million CNY | 125.71% |
| 2007 | 35.36 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 26.67 Billion CNY | 5.71% |
| 2024 Q2 | 27.31 Billion CNY | -18.6% |
| 2023 Q2 | 20.96 Billion CNY | 15.89% |
| 2023 Q1 | 18.08 Billion CNY | 41.37% |
| 2023 Q3 | 24.55 Billion CNY | 17.16% |
| 2023 FY | 25.23 Billion CNY | 97.23% |
| 2023 Q4 | 25.23 Billion CNY | 2.75% |
| 2022 FY | 12.79 Billion CNY | 100.52% |
| 2022 Q1 | 6.6 Billion CNY | 3.49% |
| 2022 Q2 | 9.46 Billion CNY | 43.31% |
| 2022 Q3 | 10.77 Billion CNY | 13.87% |
| 2022 Q4 | 12.79 Billion CNY | 18.74% |
| 2021 Q3 | 6.59 Billion CNY | 23.7% |
| 2021 Q1 | 6.15 Billion CNY | 0.57% |
| 2021 FY | 6.38 Billion CNY | 4.3% |
| 2021 Q2 | 5.33 Billion CNY | -13.36% |
| 2021 Q4 | 6.38 Billion CNY | -3.23% |
| 2020 Q4 | 6.11 Billion CNY | -5.96% |
| 2020 Q2 | 5.86 Billion CNY | 3.51% |
| 2020 Q1 | 5.66 Billion CNY | 35.17% |
| 2020 FY | 6.11 Billion CNY | 45.87% |
| 2020 Q3 | 6.5 Billion CNY | 10.87% |
| 2019 Q1 | 2.95 Billion CNY | 6.27% |
| 2019 FY | 4.19 Billion CNY | 51.07% |
| 2019 Q4 | 4.19 Billion CNY | -4.55% |
| 2019 Q3 | 4.39 Billion CNY | 4.3% |
| 2019 Q2 | 4.21 Billion CNY | 42.79% |
| 2018 FY | 2.77 Billion CNY | 26.29% |
| 2018 Q1 | 2.07 Billion CNY | -5.47% |
| 2018 Q2 | 2.28 Billion CNY | 9.95% |
| 2018 Q3 | 1.96 Billion CNY | -14.08% |
| 2018 Q4 | 2.77 Billion CNY | 41.43% |
| 2017 Q2 | 1.84 Billion CNY | 61.56% |
| 2017 FY | 2.19 Billion CNY | 269.64% |
| 2017 Q4 | 2.19 Billion CNY | 9.74% |
| 2017 Q3 | 2 Billion CNY | 8.74% |
| 2017 Q1 | 1.14 Billion CNY | 91.73% |
| 2016 FY | 594.63 Million CNY | 102.44% |
| 2016 Q1 | 491.71 Million CNY | 67.4% |
| 2016 Q4 | 594.63 Million CNY | 27.88% |
| 2016 Q2 | 450.19 Million CNY | -8.44% |
| 2016 Q3 | 464.99 Million CNY | 3.29% |
| 2015 Q2 | 425.44 Million CNY | 12.85% |
| 2015 FY | 293.73 Million CNY | -12.18% |
| 2015 Q4 | 293.73 Million CNY | -19.43% |
| 2015 Q3 | 364.58 Million CNY | -14.31% |
| 2015 Q1 | 376.99 Million CNY | 12.71% |
| 2014 Q2 | 142.03 Million CNY | -25.14% |
| 2014 FY | 334.47 Million CNY | 22.1% |
| 2014 Q4 | 334.47 Million CNY | 88.91% |
| 2014 Q3 | 177.05 Million CNY | 24.65% |
| 2014 Q1 | 189.73 Million CNY | -30.74% |
| 2013 Q4 | 273.94 Million CNY | 17.69% |
| 2013 FY | 273.94 Million CNY | 287.37% |
| 2013 Q1 | 117.93 Million CNY | 66.77% |
| 2013 Q2 | 199.14 Million CNY | 68.86% |
| 2013 Q3 | 232.76 Million CNY | 16.88% |
| 2012 Q1 | 12.4 Million CNY | 0.0% |
| 2012 FY | 70.71 Million CNY | 0.0% |
| 2012 Q2 | 42.24 Million CNY | 240.66% |
| 2012 Q3 | 43.36 Million CNY | 2.66% |
| 2012 Q4 | 70.71 Million CNY | 63.07% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q3 | 20 Million CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q2 | 109.45 Million CNY | 0.0% |
| 2010 Q4 | - CNY | -100.0% |
| 2010 Q3 | 58.06 Million CNY | -46.95% |
| 2009 Q4 | 60.96 Million CNY | 0.0% |
| 2009 FY | 60.96 Million CNY | -23.61% |
| 2008 FY | 79.8 Million CNY | 125.71% |
| 2007 FY | 35.36 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 134.33 Million HKD | -18684.275% |
| Lee & Man Chemical Company Limited | 678.91 Million HKD | -3616.792% |